Remarkably, milk production by Plg-/-females is not affected at either 2 or 7 days postpartum [15]. in macrophage recruitment. As a contributing mechanism, the capacity of Plg-RKT-/-macrophages for plasminogen binding was markedly decreased. == Conclusions == These studies demonstrate Mesaconine that Plg-RKTis required for plasminogen binding and macrophage migrationin vivo. In addition , Plg-RKTdeficiency is not compatible with survival of the species, due to death of all offspring of Plg-RKT-/-females. This new mouse model will be important for future studies aimed at delineating the role of cell surface plasminogen activation in challenge and disease modelsin vivo. Keywords: Inflammation, Peritonis, Plasminogen, Receptors, Cell Surface, Thioglycolates == Introduction == The activation of plasminogen Rabbit Polyclonal to STAT1 (phospho-Ser727) to the broad spectrum serine protease, plasmin, is markedly enhanced when plasminogen is co-localized with plasminogen activators on cell surfaces [reviewed Mesaconine in [1]]. Plasmin remains bound to the cell surface where it is relatively protected from inactivation by 2-antiplasmin [reviewed in [1]]. Thus, a local nidus of cell membrane-associated broad spectrum proteolytic activity is achieved, a key feature of pathological processes in which plasmic degradation of extracellular matrices is required for Mesaconine efficient cell migration [reviewed in [2]]. Studies with plasminogen null (Plg-/-) mice have demonstrated a major physiologic role for plasminogen in functions consistent with a role for the interaction of plasminogen with cell surfaces. These include wound healing, tissue remodeling, tumor growth and dissemination, and inflammation [reviewed in [2]]. In particular, these studies have demonstrated a key role for cell surface binding of plasminogen via proteins exposing a C-terminal basic residue in the inflammatory cell recruitment response [3-5]. The plasminogen receptor, Plg-RKT, is a recently discovered integral membrane protein that binds plasminogen via a C-terminal lysine exposed on the cell surface [6, 7]. Plg-RKTalso binds tissue plasminogen activator (tPA) and promotes tPA-dependent plasminogen activation [6, 8]. Furthermore, Plg-RKTis highly colocalized with the urokinase plasminogen activator (uPA) receptor (uPAR) [6, 8] and promotes uPA-dependent plasminogen activation [9]. Notably, Plg-RKTis highly conserved with high interspecies homology, high identity, no gaps in the sequences and the presence of a C-terminal lysine for all 36 mammalian orthologs for which sequence information is available [see [7], Table 2 for alignment of 20 representative orthologs]. In order to assess the physiological function of Plg-RKTwe disrupted the PLGRKT gene in mice, and characterized the effect of Plg-RKTdeletion on reproduction, viability, health, spontaneous thrombosis, and inflammation. == Materials and Methods == == Proteins == Human Glu-plasminogen was purified as described [10, 11] and labeled with fluorescein isothiocyanate (FITC) using a FITC labeling kit (EMD, EMD Millipore, Darmstadt, Germany). Phycoerythrin labeled annexin V was from R&D Systems, Minneapolis, MN. Antibodies used were: polyclonal rabbit anti-casein (Abbiotec, San Diego, CA), anti–actin MAb (LI-COR, Lincoln, NE), and HRP-conjugated secondary antibody (Biosource, San Diego, CA) or appropriate fluoresceinated secondary antibodies (LI-COR, Lincoln, NE). == Mice == Plg-RKT-/-mice Mesaconine were generated as described inFig. 1and backcrossed ten generations into the C57Bl/6J background. == Determine 1 . Generation and characterization of Plg-RKTdeficient mice. == (A)Construction of a conventional targeting vector for Plg-RKT. An 18. 90 kb region was first subcloned from a positively identified 129 BAC clone (RPCI-22: 24B9) using a homologous recombination-based technique. The targeting vector was designed such that the long homology arm extended 5. 40 kb 3 to the 3 end of a pGK-gb2 loxP/FRT-flanked neomycin cassette. The short homology arm was located on the 5 side of the neomycin cassette and was 3. 08 kb long. An Nde I site was engineered into the neomycin cassette for Southern blot analysis. The targeting vector was confirmed by restriction analysis after each modification step and by sequencing using primers designed to read from the selection cassette into the a few end of the short homology arm and the 5 end of the long homology arm, or from primers that anneal to the vector sequence, and read into the 5 and a few ends of the BAC sub clone. The BAC was subcloned into a 2 . 4 kb (pSP72, Promega) backbone vector that contains an ampicillin selection cassette for retransformation of the construct prior to electroporation. The total size of the targeting construct was 10. 18 kb. The pGK-gb2 loxP/FRT-flanked neomycin cassette was inserted into the gene. Exons 4-7 were conventionally targeted and the neomycin cassette replaced 10. 42 kb of this gene. The targeting construct was linearized using Not I prior to electroporation.